No Data
No Data
CorMedix Inc. (NASDAQ:CRMD) Q1 2024 Earnings Call Transcript
CorMedix Price Target Maintained With a $10.00/Share by Needham
CorMedix Price Target Maintained With a $10.00/Share by Needham
Express News | Needham Reiterates Buy on Cormedix, Maintains $10 Price Target
Cormedix Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 90.48% Needham → $10 Reiterates Buy → Buy 04/09/2024 261.9% JMP Securities → $19 Reiterates Mar
CorMedix Inc. (CRMD) Q1 2024 Earnings Call Transcript
CorMedix Inc. (CRMD) Q1 2024 Earnings Call Transcript
Analysts' Opinions Are Mixed on These Healthcare Stocks: Beam Therapeutics (BEAM), Cormedix (CRMD) and Applied Therapeutics (APLT)